Catherine Mackey - Avid Bioservices Independent Director
Director
Dr. Catherine J. Mackey, Ph.D. is Independent Director of the Company. She is an experienced leader, director and advisor with more than 30 years of research and development and operations experience in the pharmaceutical, biotechnology and agricultural industries. She is chairman of the board of Cour Pharmaceutical Development, a privately held, clinical stage company focused on immunomodulation. She is also a member of the board of directors and audit committee of GW Pharmaceuticals PLC, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas, and a member of the board of directors of Poseida Therapeutics, Inc., a privately held, clinical stage company developing next generation cell therapies for cancer. Dr. Mackey served as a member of the board of directors and the compensation committee of YM Biosciences Inc., a Canadian drug development company, from 2011 to 2013. She also served as a member of the board of directors, the audit committee, and nominating and corporate governance committee of Sequenom Inc., a life sciences company, from 2015 to 2016. In addition, she serves on the board of directors of Rady Childrens Hospital and as an advisor to several companies. Dr. Mackey previously served as senior vice president of Pfizer Worldwide Research and Development and director of Pfizers La Jolla Laboratories, where she built Pfizer La Jolla into one of Pfizers main pharmaceutical research and development sites with over 1, 000 employees and a robust drug pipeline. Prior to that role, she served as head of Strategic Alliances and Genomic and Proteomic Sciences for Pfizer. Dr. Mackey spent the first part of her career in agricultural biotechnology, including as vice president of DEKALB Genetics, Inc., an international researcher, producer, and marketer of seed since 2019.
| Age | 62 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 714 508 6100 |
| Web | http://www.avidbio.com |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of 1.98 % which means that it generated a profit of $1.98 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.72 %, meaning that it generated $6.72 on every $100 dollars invested by stockholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 21.57 M in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. Avid Bioservices has a current ratio of 1.82, which is within standard range for the sector. Debt can assist Avid Bioservices until it has trouble settling it off, either with new capital or with free cash flow. So, Avid Bioservices' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avid Bioservices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avid to invest in growth at high rates of return. When we think about Avid Bioservices' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Alison Carnwath | PACCAR Inc | 64 | |
| Sandra Pierce | American Axle Manufacturing | 62 | |
| Kenneth Hastings | PACCAR Inc | 65 | |
| Thomas Walker | American Axle Manufacturing | 73 | |
| Peter Lyons | American Axle Manufacturing | 65 | |
| George Thanopoulos | American Axle Manufacturing | 53 | |
| Graham MSc | Abcellera BiologicsInc | N/A | |
| Loren Easton | American Axle Manufacturing | N/A | |
| William Kozyra | American Axle Manufacturing | 63 | |
| Robert Wills | Oncternal Therapeutics | 64 | |
| Roderick McGeary | PACCAR Inc | 67 | |
| Elizabeth Chappell | American Axle Manufacturing | 63 | |
| Herbert Parker | American Axle Manufacturing | 63 | |
| Gregory Spierkel | PACCAR Inc | 60 | |
| Franklin Feder | PACCAR Inc | 66 | |
| Kevin Penn | American Axle Manufacturing | N/A | |
| Luiz Kaufmann | PACCAR Inc | 71 | |
| James McCaslin | American Axle Manufacturing | 72 | |
| Forest Farmer | American Axle Manufacturing | 72 | |
| John Pigott | PACCAR Inc | 54 | |
| Larry Switzer | American Axle Manufacturing | 68 | |
Management Performance
| Return On Equity | 6.72 | |||
| Return On Asset | 1.98 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, CFO | ||
| Stephen Hedberg, Principal Financial Officer, Principal Accounting Officer | ||
| Mark Ziebell, Vice President General Counsel, Corporate Secretary | ||
| Paul Lytle, CFO | ||
| Catherine Mackey, Independent Director | ||
| Roger Lias, President CEO | ||
| Gregory Sargen, Director | ||
| Mark Bamforth, Independent Director | ||
| Patrick Walsh, Independent Director | ||
| Richard Hancock, Director | ||
| Joel McComb, Director | ||
| Joseph Carleone, Director | ||
| Magnus Schroeder, Vice President - Process Sciences |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to OReilly Automotive could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OReilly Automotive when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OReilly Automotive - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OReilly Automotive to buy it.
The correlation of OReilly Automotive is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OReilly Automotive moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OReilly Automotive moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OReilly Automotive can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |